Search the Newsreel

CODX Stock Explodes Over 630% In Six Sessions – Retail Traders Bet The Rally Isn’t Over Yet

Co-Diagnostics (CODX) shares surged by nearly 80% on Tuesday, extending a six-session rally that has seen the stock climb over 630%. This surge is attributed to the company's expanded efforts to develop a PCR test for the Bundibugyo strain of the Ebola virus, amidst …

Co-Diagnostics Reports Second Quarter 2026 Financial Results

Co-Diagnostics, Inc. announced its financial results for the second quarter ended June 30, 2026, reporting revenue of $0.17 million and a net loss of $6.3 million. The company highlighted significant operational progress, including advancing manufacturing in Saudi Arabia, expanding commercial outreach in Europe and …

KRSNAA: Revenue and profit rose, dividend declared, and warrants issued to promoters amid tax appeals

EKF Diagnostics Cancels 40,000 Shares in Targeted Buyback

Needham reiterates Buy on Lucid Diagnostics stock, $3 target

Needham has reiterated a Buy rating and a $3.00 price target for Lucid Diagnostics Inc (NASDAQ:LUCD), citing potential upside from its current stock price of $0.97. The firm anticipates increased revenue growth as the company gains coverage for its EsoGuard test, especially with a …

Innospec stock hits 52-week high at 94.67 USD

Innospec Inc. (IOSP) stock has reached a new 52-week high of $94.67, driven by strong performance including a 12.15% gain over the past year and a 23% year-to-date return in 2026. This milestone follows impressive Q2 2026 financial results, where the company surpassed earnings …

Innospec stock hits 52-week high at 94.67 USD By Investing.com

Innospec Inc. (IOSP) stock reached a new 52-week high of $94.67, driven by strong Q2 2026 financial results that surpassed analyst expectations for both earnings and revenue. The specialty chemicals company boasts a market capitalization of $2.31 billion and a P/E ratio of 19.08, …

Ainos Surpasses 878 Million Real-World Data Points, Up 43% in 23 Days as 1,400-System AI Nose Semiconductor Deployment Advances

Ainos Inc. announced its AI Nose platform has surpassed 878 million real-world smell and chemical data points, a 43% increase in 23 days, primarily from semiconductor manufacturing. This milestone reflects significant progress in deploying 1,400 AI Nose systems, expanding its real-world data foundation and …

Lucid Diagnostics Inc. (LUCD) Reports Q2 Loss, Lags Revenue Estimates

Lucid Diagnostics Inc. (LUCD) reported a wider-than-expected Q2 loss of $0.06 per share, missing the Zacks Consensus Estimate of a $0.04 loss, and its revenues of $1.47 million also fell short of estimates. The company has underperformed the S&P 500 year-to-date, and its shares …

Earnings call transcript: Lucid Diagnostics posts Q2 2026 revenue beat, shares slip

Lucid Diagnostics (LUCD) reported a Q2 2026 revenue beat of $1.47 million, surpassing expectations by 2.8%, though shares slipped slightly. The company matched Wall Street forecasts with a loss of 6 cents per share, and its EsoGuard test volume remained within target. Management highlighted …

Lucid Diagnostics earnings matched, revenue topped estimates

Cronos (CRON) Q2 2026 Earnings Call Transcript

Cronos (CRON) reported stellar Q2 2026 financial results, achieving record net revenue of $53 million, gross profit of $28.5 million, and adjusted EBITDA of $13.1

Radiopharm Theranostics (RADX) seeks shareholder approval for placements, SPP and new warrants

Radiopharm Theranostics (RADX) is seeking shareholder approval for a multi-component capital raise, including placements, a share purchase plan (SPP), and various options and warrants, at a virtual extraordinary general meeting on September 11, 2026. The company is asking shareholders to ratify previously issued shares …

Lucid Diagnostics Non-GAAP EPS of -$0.06 misses by $0.01, revenue of $1.47M misses by $0.46M

* Lucid Diagnostics press release [https://seekingalpha.com/pr/20618076-lucid-diagnostics-provides-business-update-and-reports-second-quarter-2026-financial-results] (LUCD [https://seekingalpha.com/symbol/LUCD]): Q2 Non-GAAP EPS of -$0.06 misses by $0.01. * Revenue of $1.47M (+26.7% Y/Y) misses by $0.46M. * Processed 2,770 EsoGuard tests * Lucid had cash and cash equivalents of $33.4 million as of June 30, …

Lucid Diagnostics Secures EsoGuard Policy Adopted by Health Plans

Quest Diagnostics Incorporated (NYSE:DGX) Plans Quarterly Dividend of $0.86

Quest Diagnostics (NYSE:DGX) has declared a quarterly dividend of $0.86 per share, payable on October 21st to shareholders of record on October 6th. This dividend represents an annualized payout of $3.44 and a 1.4% yield. The company has a strong dividend history, having increased …

BCAL Diagnostics Limited (ASX:BDX) Share Price Falls 5.08% as Stock Trades Within Daily Range

Atomo Diagnostics Limited (ASX:AT1) Share Price Remains Unchanged as Stock Trades Within Daily Range

Suraksha Diagnostic releases Q4FY26 earnings call audio for investor review

Suraksha Diagnostic Q4 Results: Earnings call audio released for FY26 review

Earnings To Watch: Lucid Diagnostics Inc (LUCD) Q2 2026 -- GF Value Sees 5% Upside

Lucid Diagnostics Inc (LUCD) is scheduled to release its Q2 2026 earnings on August 13, 2026, with revenue estimates at $1.44 million and earnings at $-0.07 per share. Analysts' revenue estimates for the full year 2026 and 2027 have declined, as have earnings estimates …

Radiopharm Theranostics Calls Virtual Extraordinary General Meeting for September 2026

Suraksha Diagnostic Q1 Results: Net profit rises to ₹18.6 crore, up from loss

Suraksha Diagnostic consolidated net profit rises 38.40% in the June 2026 quarter

How Sonos’ Profit Return, CFO Exit and Buybacks Will Impact Sonos (SONO) Investors

Sonos (SONO) recently announced its Q3 2026 results, reporting a return to profit with US$29.85 million in net income and US$375.26 million in sales. The company also completed a US$115.32 million share repurchase program, announced the retirement of its CFO Saori Casey, and appointed …

Ainos Will Show How Machines Sense Chemical Signals in Air

Ainos (NASDAQ:AIMD) will showcase its Environmental Intelligence solutions for Physical AI, including the AI Nose environmental sensing platform and Atmosphere Engine environmental control solution, at SEMICON Taiwan 2026. These technologies are designed to enable intelligent machines to detect and interpret airborne chemical signals, converting …

Radiopharm Theranostics Calls Extraordinary General Meeting to Ratify Placement Shares and Approve Capital Raising

Radiopharm Theranostics Limited (ASX:RAD) has announced an Extraordinary General Meeting (EGM) for September 11, 2026, to seek shareholder approval for various share issuances and capital raising activities. Shareholders will vote on ratifying previously issued placement shares and ADS shares, and approving the issuance of …

Radiopharm Theranostics Announces Virtual EGM on September 11, 2026 to Approve Share Issuances and Capital Raise

Radiopharm Theranostics Limited (ASX:RAD) has scheduled a virtual Extraordinary General Meeting (EGM) for September 11, 2026, to seek shareholder approval for various share issuances and capital raising initiatives. Shareholders will vote on ratifying previously issued shares, approving new placements to sophisticated investors, and endorsing …

Lucid Diagnostics (NASDAQ:LUCD) Issues Earnings Results, Misses Estimates By $0.04 EPS

Lucid Diagnostics (NASDAQ:LUCD) reported a Q2 loss of $0.08 per share, missing analyst estimates by $0.04, despite revenue of $1.47 million which slightly exceeded expectations. Shares rose 1.9% following the announcement but remain near their 12-month low. Insider buying was noted, with Director Dennis …

Earnings call transcript: Sera Prognostics misses Q2 2026 estimates as growth builds

Sera Prognostics earnings missed by $0.03, revenue fell short of estimates

Quest Diagnostics Keeps Quarterly Dividend at $0.86 per Share, Payable Oct. 21, to Shareholders of Record Oct. 6

Quest Diagnostics (DGX) announced that it will maintain its quarterly dividend at $0.86 per share. This dividend will be payable on October 21, 2026, to shareholders of record as of October 6, 2026. The announcement was published on August 12, 2026, by MT Newswires.

Sera Prognostics (NASDAQ:SERA) Releases Quarterly Earnings Results, Misses Expectations By $0.03 EPS

Century Casinos (CNTY) awards 4,000 restricted stock units to director Etess

Century Casinos Inc. (CNTY) has granted 4,000 Restricted Stock Units (RSUs) to director Mitchell G. Etess. These RSUs represent a contingent right to receive one share of CNTY common stock each, vesting on August 11, 2027, with shares delivered on August 12, 2027. The …

Sera Prognostics, Inc. (SERA) Reports Q2 Loss, Misses Revenue Estimates

Lucid Diagnostics (LUCD) Releases Q2 2026 Earnings: Revenue Up 26.7% but Losses Continue

Lucid Diagnostics (LUCD) reported a 26.7% increase in Q2 2026 revenue, reaching $1.5 million, which slightly exceeded analyst expectations. Despite this top-line growth, the company continued to post significant losses, with a net loss of $14.7 million. Insider trading activity shows one purchase in …